Occult hepatitis B virus infection in Egyptian hemodialysis patients with or without hepatitis C virus infection

References

• Kennedy M, Alexopoulos SP. Hepatitis B virus infection and liver transplantation. Curr Opin Organ Transplant. 2010;15(3): 310–315.
   PubMed Web of Science ®Google Scholar
• Zaghloul H, El-Sherbiny W. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells. Immunol Invest. 2010;39(3):284–291.
   PubMed Web of Science ®Google Scholar
• Paraskevis D, Beloukas A, Haida C, et al. Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA. Virol J. 2010;12:7:57.
   Google Scholar
• Cao GW. Clinical relevance and public health significance of hepatitis B virus genomic variations. World J Gastroenterol. 2009; 15(46):5761–5769.
   Web of Science ®Google Scholar
• Torbenson M, Thomas D. Occult hepatitis B. Lancet Infect Dis. 2002; 2(8):479–486.
   PubMed Web of Science ®Google Scholar
• Allain JP. Occult hepatitis B infection. Transfus Clin Biol. 2004;11(1): 18–25. French.
   Web of Science ®Google Scholar
• Torbenson M, Kannangai R, Astemborski J, et al. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology. 2004;39(1):51–57.
   Web of Science ®Google Scholar
• Goral V Ozkul H, Tekes S, et al. Prevalence of occult HBV infection in hemodialysis patients with chronic HCV. World J Gastroenterol. 2006;12(21):3420–3424.
   Web of Science ®Google Scholar
• Hu KQ. Occult hepatitis B infection and its clinical implications. J Viral Hepat. 2002;9:243–257.
   PubMed Web of Science ®Google Scholar
• Siagris D, Christofidou M, Triga K, et al. Occult hepatitis B virus in hemodialysis patients with chronic HCV infection. J Nephrol. 2006; 19(3):327–333.
   Web of Science ®Google Scholar
• Fabrizi F, Lunghi G, Martin P. Hepatitis B virus infection in hemodialysis: Recent discoveries. J Nephrol. 2002;15(5):463–468.
   Web of Science ®Google Scholar
• Otedo AE, Mc’Ligeyo SO, Okoth FA, Kayima JK. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. S Afr Med J. 2003;93(5):380–384.
   PubMed Web of Science ®Google Scholar
• Anwar W, Sarwar M, Hussain AB, Tariq WU, Saif M. Significance of occult HBV infection in patients with chronic hepatitis C. J Coll Physicians SurgPak 2006;16(3):192–195.
   Google Scholar
• Azab M el-S, el Zayat EA. Evaluation of purified antigens in haemagglutination test (IHA) for determination of crosses reactivities in diagnosis of fascioliasis and schistosomiasis. J Egypt Soc Parasitol. 1996;26(3):677–685.
   Google Scholar
• Kaneko S, Feinstone SM, Miller RH. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J Clin Microbiol. 1989;27(9):1930–1933.
   Web of Science ®Google Scholar
• Minuk GY, Sun DF, Greenberg R, et al. Occult hepatitis B virus in a North American adult hemodialysis patient population. Hepatology. 2004;40(5):1072–1077.
   Web of Science ®Google Scholar
• Yakaryilmaz F, Gurbuz OA, Guliter S, et al. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail. 2006;28(8):729–735.
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Messa PG, Lunghi G, et al. Occult hepatitis B virus infection in dialysis patients: A multicentre survey. Aliment Pharmacol Ther. 2005;21(11):1341–1347.
   Web of Science ®Google Scholar
• Besisik F, Karaca C, Akyuz F, et al. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol. 2003;38(4):506–510.
   PubMed Web of Science ®Google Scholar
• Kreutz C. Molecular, immunological, and clinical properties of mutated hepatitis B viruses. J Cell Mol Med. 2002;6(1):113–143.
   Web of Science ®Google Scholar
• Preisler AS, Schlayer HJ, Peters T, et al. Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch Virol. 1993; 133(3–4):385–396.
   Web of Science ®Google Scholar
• Lili KS, Dagmar P, Christian M. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol. 2000;3:785–790.
   Google Scholar
• Gaeta GB, Rapicetta M, Sardaro C, et al. Prevalence of anti-HCV antibodies in patients with chronic liver disease and its relationship to HBV and HDV infections. Infection. 1990;18(5):277–279.
   Web of Science ®Google Scholar
• Feldman M, Scharashmidt BF, Sleisenger MH, et al. Gastrointestinal and Liver Disease. Pathophysiology, Diagnosis, and Management. Vol 2. 6th ed. Philadelphia, PA: WB Saunders; 1998.
   Google Scholar
• Shire NJ, Rouster SD, Rajicic N, et al. Occult hepatitis B in HIV-infected patients. J Acquir Immune Defic Syndr. 2004;36:869–875.
   PubMed Web of Science ®Google Scholar
• Nalpas B, Pourcel C, Feldmann G, et al. Chronic alcohol intoxication decreases the serum level of hepatitis B surface antigen in transgenic mice. J Hepatol. 1992;15(1–2):118–124.
   Web of Science ®Google Scholar
• Oesterreicher C, Hammer J, Koch J, et al. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int. 1995;48(6):1967–1971.
   Web of Science ®Google Scholar
• Helmy A, Al-Sebayel MI. Isolated antibody to hepatitis B core antigen in patients with chronic hepatitis C virus infection. World J Gastroenterol. 2006;12(27):4406–4410.
   Web of Science ®Google Scholar
• Jilg W, Sieger E, Zachoval R, et al. Individuals with antibodies against hepatitis B core antigen as the only serological marker of hepatitis B infection, high prevalence of carriers of hepatitis B and C virus. J Hepatol. 1995;23(1):14–20.
   Web of Science ®Google Scholar
• El-Sadawy M, Ragab H, El-Toukhy H, et al. Hepatitis C virus infection at Sharkia Governorate, Egypt: Seroprevalence and associated risk factors. J Egypt Soc Parasitol. 2004;34 Suppl 1:367–384.
   Google Scholar
• El-Gaafary M, Abou-Fetouh A, Zaki M, et al. Some epidemiological aspects of patients with end stage renal diseases. J Egypt Public Health Assoc. 2000;75(1–2):107–129.
   Google Scholar
• Steinfelder S, Andersen JF, Cannons JL, et al. The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1). J Exp Med. 2009;206(8): 1681–1690.
   Web of Science ®Google Scholar
• Emam EA, Emam M, Shehata AE, Emara M. Impact of Schistosoma mansoni co-infection on serum profile of interferon-gamma, interleukin-4 and interleukin-10 in patients with chronic hepatitis C virus infection. Egypt J Immunol. 2006;13(2):33–40.
   Google Scholar
• Fabrizi F, Dixit V, Bunnapradist S, et al. Meta-analysis: The dialysis mode and immunological response to hepatitis B vaccine in dialysis population. Aliment Pharmacol Ther. 2006;23(8): 1105–1112.
   PubMed Web of Science ®Google Scholar
• Shatat HZ, Kotkat AM, Farghaly AG. Immune response to hepatitis B vaccine in hemodialysis patients. J Egypt Public Health Assoc. 2000; 75(3–4):257–275.
   Google Scholar
• Fabrizi F, Lunghi G, Finazzi S, et al. Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis. Am J Kid Dis. 2001;38(5):1009–1015.
   Web of Science ®Google Scholar
• Yasuda K, Okuda K, Endo N, et al. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: Clinical and biochemical appraisal. Gastroenterology. 1995;109(4):1295–1300.
   PubMed Web of Science ®Google Scholar